SNWVNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
SANUWAVE Health, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 6, 2026
$4.83−0.13 (-2.62%)
Close on Oct 19, 2026
- Market cap
- $41.54M
- P/E (TTM)
- 11.8
- Dividend yield
- –
SANUWAVE Health statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Surgical & Medical Instruments & Apparatus companies for comparison
Valuation
| Measure | SANUWAVE Health | Industry median |
|---|---|---|
| Market Cap | $41.55M | $230.55M |
| Enterprise Value | $32.17M | $202.97M |
| PS Ratio | 0.94 | 3.11 |
| PB Ratio | 14.91 | 3.14 |
| P/FCF Ratio | 9.79 | 27.25 |
| P/OCF Ratio | 7.96 | 22.35 |
Enterprise value
| Measure | SANUWAVE Health | Industry median |
|---|---|---|
| EV / Sales | 0.73 | 2.92 |
| EV / EBITDA | 12.33 | 19.86 |
| EV / EBIT | 21.42 | 24.88 |
| EV / FCF | 7.58 | 27.85 |
Income (trailing twelve months)
| Measure | SANUWAVE Health | Industry median |
|---|---|---|
| Revenue | $44.02M | $102.39M |
| Gross Profit | $33.60M | $60.36M |
| Operating Income | $1.50M | -$4.31M |
| Net Income | $15.26M | -$6.57M |
| EBITDA | $2.61M | -$1.98M |
Margins
| Measure | SANUWAVE Health | Industry median |
|---|---|---|
| Gross Margin | 76.3% | 55.1% |
| Operating Margin | 3.41% | -6.04% |
| Profit Margin | 34.7% | -10.5% |
| EBITDA Margin | 5.93% | -2.67% |
| FCF Margin | 9.64% | -0.30% |
Returns
| Measure | SANUWAVE Health | Industry median |
|---|---|---|
| Return on Assets (ROA) | 43.8% | -13.3% |
| Return on Capital Employed (ROCE) | 8.15% | -9.07% |
Growth
| Measure | SANUWAVE Health | Industry median |
|---|---|---|
| Revenue Growth (YoY) | 12.7% | 8.85% |
| Revenue Growth (3Y CAGR) | 38.1% | 7.08% |
| Revenue Growth (5Y CAGR) | 61.1% | 11.8% |
Balance sheet
| Measure | SANUWAVE Health | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $9.38M | $37.33M |
| Net Cash (Debt) | $9.38M | $3.92M |
| Net Cash Per Share | $1.09 | $0.28 |
| Equity (Book Value) | $2.79M | $57.36M |
| Book Value Per Share | $0.32 | $2.81 |
| Tangible Book Value | -$7.36M | $10.71M |
| Working Capital | $5.03M | $54.64M |
Financial position
| Measure | SANUWAVE Health | Industry median |
|---|---|---|
| Current Ratio | 1.28 | 2.50 |
| Quick Ratio | 0.84 | 1.54 |
Cash flow (trailing twelve months)
| Measure | SANUWAVE Health | Industry median |
|---|---|---|
| Operating Cash Flow | $5.22M | -$653.46K |
| Capital Expenditures | -$978.00K | -$3.69M |
| Free Cash Flow | $4.24M | -$835.02K |
| FCF Per Share | $0.49 | -$0.02 |
Efficiency
| Measure | SANUWAVE Health | Industry median |
|---|---|---|
| Asset Turnover | 1.26 | 0.59 |
| Inventory Turnover | 1.61 | 2.21 |
| Revenue Per Employee | $800.40K | $322.57K |
| Profits Per Employee | $277.44K | -$51.88K |
| Employee Count | 55 | 185 |
Dividends and yields
| Measure | SANUWAVE Health | Industry median |
|---|---|---|
| Earnings Yield | 36.7% | -6.91% |
| FCF Yield | 10.2% | -0.56% |
Shares
| Measure | SANUWAVE Health | Industry median |
|---|---|---|
| Shares Outstanding | 8,602,310 | 44,856,700 |
| Shares Change (YoY) | 19.8% | 3.35% |
| Shares Change (QoQ) | 0.09% | 0.27% |
| Shares Held by Institutions | 37.3% | 63.5% |
Scores
| Measure | SANUWAVE Health | Industry median |
|---|---|---|
| Altman Z-Score | -7.12 | 1.95 |
| Piotroski F-Score | 6 | 5 |
| Beneish M-Score | -0.83 | -2.64 |
Calculated by StockData from SANUWAVE Health's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.